submitted by mesoman 660 days ago (via us.rd.yahoo.com)
Alfacell Corp. said Wednesday 290 patients have died during its Phase IIIb clinical trial of drug candidate Onconase as a treatment for malignant mesothelioma, a cancer of the sac lining around the chest or stomach.
submitted by mesoman 660 days ago (via us.rd.yahoo.com)
Alfacell Corporation today announced it has confirmed that 290 evaluable events have occurred in the Phase IIIb clinical trial of its lead compound, ONCONASE, for the treatment of patients with unresectable malignant mesothelioma.
submitted by mesoman 660 days ago (via us.rd.yahoo.com)
SC says REL team can bid for Mumbai sea link project New Delhi, Sept. 11 The Supreme Court on Tuesday allowed the consortium of Reliance Energy Ltd (REL) of Anil Ambani group and Hyundai Engineering Construction Co (HDEC) to submit its bid for the Rs 2,600-crore sea link project between Mumbai ...
submitted by mesoman 660 days ago (via us.rd.yahoo.com)
A MECHANIC suffering from a terminal cancer which he claims was caused by asbestos while working in Ansley has launched a legal battle for up to £200,000 compensation.
submitted by mesoman 660 days ago (via us.rd.yahoo.com)
Akurdi plant not shut down, says Bajaj Auto Pune, Sept. 10 Bajaj Auto Ltd on Monday denied that the Akurdi plant near Pune has been shut down, even as workers claim that production of two-wheelers has been totally discontinued from September 1 and that the assembly lines are ...
submitted by mesoman 660 days ago (via us.rd.yahoo.com)
On this sixth anniversary of 9/11, we are reminded of all we owe to those who place their lives on the line in the service of our county and our communities.
submitted by mesoman 660 days ago (via us.rd.yahoo.com)
Alfacell Corp. said Wednesday 290 patients have died during its Phase IIIb clinical trial of drug candidate Onconase as a treatment for malignant mesothelioma, a cancer of the sac lining around the chest or stomach.
submitted by mesoman 660 days ago (via us.rd.yahoo.com)
Alfacell Corporation today announced it has confirmed that 290 evaluable events have occurred in the Phase IIIb clinical trial of its lead compound, ONCONASE, for the treatment of patients with unresectable malignant mesothelioma.
